Business Description
Surrozen Inc
NAICS : 541714
SIC : 2833
171 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080
Description
Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.82 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0 | |||||
| Beneish M-Score | 0 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.71 | |||||
| 9-Day RSI | 50.57 | |||||
| 14-Day RSI | 50.37 | |||||
| 6-1 Month Momentum % | 25.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.79 | |||||
| Quick Ratio | 11.79 | |||||
| Cash Ratio | 11.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -32.96 | |||||
| ROA % | -27.32 | |||||
| ROIC % | -131.07 | |||||
| ROC (Joel Greenblatt) % | -457.68 | |||||
| ROCE % | -34.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.01 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -0.22 | |||||
| EV-to-EBITDA | -0.24 | |||||
| EV-to-FCF | -0.76 | |||||
| Price-to-Net-Current-Asset-Value | 1.27 | |||||
| Price-to-Net-Cash | 1.33 | |||||
| Earnings Yield (Greenblatt) % | -466.15 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:SRZN
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0 | ||
| EPS (TTM) ($) | -1.09 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 50.37 | ||
| 14-Day ATR ($) | 0.402047 | ||
| 20-Day SMA ($) | 3.163895 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 1.98 - 14 | ||
| Shares Outstanding (Mil) | 35.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Surrozen Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||